You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

H. Jean Khoury Cure CML Consortium

Showing 1 - 25 of 5,030
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Concomitant Medications at CML Diagnosis

Completed
  • Chronic Myeloid Leukemia
  • the prevalence of comorbid conditions
  • (no location specified)
Sep 16, 2023

Care forPeripheral Musculoskeletal Disorders Referred

Recruiting
  • Musculoskeletal Disorders
  • Advanced practice physiotherapy and orthopedic surgeon management
  • Orthopedic surgeon management
  • Montréal, Quebec, Canada
    Centre de recherche de l'Hôpital Maisonneuve-Rosemont
Jan 26, 2023

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

Helicobacter Pylori Infection Trial in Taipei (susceptibility-guided tailored therapy (Group A), guidelines-recommended empiric

Recruiting
  • Helicobacter Pylori Infection
  • susceptibility-guided tailored therapy (Group A)
  • guidelines-recommended empiric therapy (Group B)
  • Taipei, Taiwan
    National Taiwan University Hospital
May 17, 2022

Chronic Myeloid Leukemia Trial in France (biological samples)

Completed
  • Chronic Myeloid Leukemia
  • biological samples
  • Belfort, France
  • +3 more
May 31, 2022

Aortic Aneurysm, Aortic Dissection, Aortic Diseases Trial in Houston

Recruiting
  • Aortic Aneurysm
  • +2 more
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Aug 27, 2021

    Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

    Completed
    • Chronic Myeloid Leukaemia
    • Rionero in Vulture, Potenza, Italy
    • +32 more
    Oct 24, 2022

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Boston, Massachusetts
    • +18 more
    Jan 19, 2023

    CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

    Recruiting
    • CML, Chronic Phase
    • CML, Accelerated Phase
    • HS-10382(Part 1: Dose escalation)
    • HS-10382(Part 2: Dose expansion)
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jan 12, 2023

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      Has Results
      • Leukemia
      • Birmingham, Alabama
      • +173 more
      Dec 1, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022

        Infection Consortium Study#1

        Not yet recruiting
        • PJI
        • Synovasure® Comprehensive Infection Panel
        • (no location specified)
        Nov 22, 2023

        Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

        Not yet recruiting
        • Leukemia,Myeloid, Chronic
        • Blood and bone marrow sample
        • Annecy, France
        • +15 more
        Nov 10, 2023

        Asciminib RMP Study

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Jul 5, 2023

        Landscape and Real-life Treatment Outcomes in Hungary: Analysis

        Completed
        • Chronic Myeloid Leukaemia
        • Budapest, Hungary
          Pfizer
        Dec 15, 2022

        Carbapenem-resistant Enterobacteriaceae Trial in Ratchathewi (Collect blood sample)

        Recruiting
        • Carbapenem-resistant Enterobacteriaceae
        • Collect blood sample
        • Ratchathewi, Bangkok, Thailand
          Phramongkutklao Hospital
        Sep 17, 2023

        Small Bowel Obstruction, Small Bowel Adhesion Trial in Saint Petersburg (Adhesiolysis, X-ray examination, Conservative

        Recruiting
        • Small Bowel Obstruction
        • Small Bowel Adhesion
        • Adhesiolysis
        • +2 more
        • Saint Petersburg, Russian Federation
        • +3 more
        Apr 21, 2023

        Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

        Recruiting
        • Healthy (For Part A)
        • Chronic Myeloid Leukemia (for Part B and C)
        • Vodobatinib (K0706) capsules
        • Downey, California
        • +69 more
        Dec 7, 2022